A Lawsuit Against Pradaxa Brings Multiple Counts Against the Manufacturer
Pradaxa received approval by the Food and Drug Administration (FDA) in October 2012 as a stroke prevention treatments for patients with non-valvular atrial fibrillation. According to the manufacturer’s website, Pradaxa is “at the forefront of a new generation of oral blood thinning treatments, which prevent... Read More